Skip to main content

Sanofi

corporate_fare Company Profile

Sanofi

SNY·NASDAQ·Life Sciences·CIK 0001121404

Sanofi is a biopharmaceutical company focused on improving people's lives through its R&D-driven and AI-powered approach. The company's activities are organized within the Biopharma operating segment, which includes categories such as Immunology, Rare Diseases, Neurology, Oncology, Other Medicines, and Vaccines. Sanofi operates in a global market characterized by a growing and aging population with high unmet medical needs. The company emphasizes innovation in R&D and advanced manufacturing to launch new medicines and vaccines. It also leverages digital technologies and advanced data analytics across sales, marketing, R&D, and manufacturing. The pharmaceutical industry faces challenges including geopolitical uncertainties, inflation, supply shortages, and government budget tightening, which put pressure on healthcare costs. Payers are scrutinizing prices and reimbursement criteria, demanding real-life outcome demonstrations for efficacy. Sanofi aims to contribute to improved patient access and the development of innovative, cost-effective medicines.

Sanofi (NASDAQ:SNY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 48 items for SNY at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Sanofi's Efdoralprin Alfa Outperforms Standard Therapy in Phase 2 AATD Trial
  • Sanofi Appoints Belén Garijo as CEO, Declares €4.12 Dividend, and Welcomes New Director
  • Sanofi Prices €2.3 Billion Multi-Tranche Bond Issue for General Corporate Purposes
  • Sanofi Secures Key FDA Approvals for Dupixent and Tzield, Despite Sarclisa Delay
  • EU Regulators Recommend Sanofi's Cenrifki for Secondary Progressive MS Approval

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
$7.85B
Diluted EPS
$6.37
Op. Cash Flow
$10.75B
Free Cash Flow
$7.21B
Gross Profit
$33.67B
Operating Income
$6.34B
Cash & Equivalents
$877M
Total Debt
$14.25B
Debt / Equity
0.20×
Shares Outstanding
1.22B sh
Source: 20-F · filed 2026-02-17 · accession 0001628280-26-008403

Insider Transactions

SNY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$46.52
52-week range · as of 2026-09-17 $40.89 – $52.68
Market cap
$111.69B
Volume
4.3M (1.0× avg)
3-mo avg 4.3M
Live data · 2026-11-22 12:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SNY - Filings & News (Page 2)

SNY
May 18, 2026, 3:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $43.44
Real-time Price: $46.52 info
Change: +$3.09 (+7%) info
Market Cap: $111.686B info
SNY
May 05, 2026, 6:06 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $43.48
Real-time Price: $46.52 info
Change: +$3.04 (+7%) info
Market Cap: $111.686B info
SNY
Apr 29, 2026, 6:04 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $45.65
Real-time Price: $46.52 info
Change: +$0.870 (+2%) info
Market Cap: $111.686B info
SNY
Apr 27, 2026, 12:58 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $46.11
Real-time Price: $46.52 info
Change: +$0.410 (+0.89%) info
Market Cap: $111.686B info
SNY
Apr 24, 2026, 6:09 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $47.45
Real-time Price: $46.52 info
Change: -$0.930 (-2%) info
Market Cap: $111.686B info
SNY
Apr 23, 2026, 7:20 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $48.48
Real-time Price: $46.52 info
Change: -$1.96 (-4%) info
Market Cap: $111.686B info
SNY
Apr 18, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $48.20
Real-time Price: $46.52 info
Change: -$1.68 (-3%) info
Market Cap: $111.686B info
SNY
Apr 15, 2026, 6:57 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $48.24
Real-time Price: $46.52 info
Change: -$1.72 (-4%) info
Market Cap: $111.686B info
SNY
Apr 07, 2026, 1:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $47.74
Real-time Price: $46.52 info
Change: -$1.22 (-3%) info
Market Cap: $111.686B info
SNY
Mar 31, 2026, 12:19 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $47.55
Real-time Price: $46.52 info
Change: -$1.03 (-2%) info
Market Cap: $111.686B info
SNY
Mar 31, 2026, 1:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $46.60
Real-time Price: $46.52 info
Change: -$0.080 (-0.17%) info
Market Cap: $111.686B info
SNY
Mar 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $47.37
Real-time Price: $46.52 info
Change: -$0.8539 (-2%) info
Market Cap: $111.686B info
SNY
Mar 18, 2026, 2:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $44.07
Real-time Price: $46.52 info
Change: +$2.45 (+6%) info
Market Cap: $111.686B info
SNY
Mar 03, 2026, 6:15 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $46.50
Real-time Price: $46.52 info
Change: +$0.020 (+0.04%) info
Market Cap: $111.686B info
SNY
Feb 23, 2026, 9:19 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $47.12
Real-time Price: $46.52 info
Change: -$0.600 (-1%) info
Market Cap: $111.686B info
SNY
Feb 17, 2026, 12:34 PM EST
Filing Type: 20-F
Importance Score:
8
Price at Filing: $46.31
Real-time Price: $46.52 info
Change: +$0.210 (+0.45%) info
Market Cap: $111.686B info
SNY
Feb 17, 2026, 9:33 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $46.29
Real-time Price: $46.52 info
Change: +$0.235 (+0.51%) info
Market Cap: $111.686B info
SNY
Feb 12, 2026, 9:17 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $46.91
Real-time Price: $46.52 info
Change: -$0.390 (-0.83%) info
Market Cap: $111.686B info
SNY
Feb 10, 2026, 9:18 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $48.66
Real-time Price: $46.52 info
Change: -$2.14 (-4%) info
Market Cap: $111.686B info
SNY
Feb 10, 2026, 6:06 AM EST
Filing Type: SC TO-T/A
Importance Score:
9
Price at Filing: $48.65
Real-time Price: $46.52 info
Change: -$2.13 (-4%) info
Market Cap: $111.686B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets